Quadrant Capital Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-14
Closed -$4K 2102
2017
Q1
$4K Hold
14
﹤0.01% 1435
2016
Q4
$4K Buy
+14
New +$4K ﹤0.01% 1333